ALMBIH — Evidencija nestasice lijekova (Bosnia & Herzegovina) (ALMBIH)

ALMBIH — Evidencija nestasice lijekova (Bosnia & Herzegovina) is the official source of medicine shortage information for Bosnia and Herzegovina (Europe). Mederti checks its register daily and links every notice back to the original publication.

Official register

lijekovi.almbih.gov.ba

Country

Bosnia and Herzegovina

Notices tracked by Mederti

150

Last checked

6 Sept 2026

Latest notices from ALMBIH

• Izosorbidmononitrat — active, medium, since 3 Sept 2026 (source)
• Iloprost — active, medium, since 2 Sept 2026 (source)
• Hepatitis-A-Virus-Antigen — active, medium, since 18 Aug 2026 (source)
• Rosuvastatin — active, medium, since 13 Aug 2026 (source)
• Natrijum-Valproat, Valproinska Kiselina — active, medium, since 12 Aug 2026 (source)
• Metronidazol — active, medium, since 7 Aug 2026 (source)
• Verapamil — active, medium, since 31 Jul 2026 (source)
• Liraglutide — active, medium, since 29 Jul 2026 (source)
• Indapamide-Hemihydrate — active, medium, since 27 Jul 2026 (source)
• Pentaeritritil Tetranitrat — active, medium, since 27 Jul 2026 (source)
• Pentaeritritil Tetranitrat — active, medium, since 24 Jul 2026 (source)
• Kapecitabin — active, medium, since 20 Jul 2026 (source)
• Hloropiramin — active, medium, since 9 Jul 2026 (source)
• Pemetreksed — active, medium, since 9 Jul 2026 (source)
• Karboplatin — active, medium, since 9 Jul 2026 (source)

Mederti is not affiliated with or endorsed by ALMBIH — Evidencija nestasice lijekova (Bosnia & Herzegovina). All notices remain the property of their publisher and are linked to the original source.